CLOVER HEALTH INVESTMENTS CO
CLOVNASDAQ🏆 #1740 by market capEarnings Nov 4US Equity
$4.48▲ $0.09 (+1.94%)
Live1h▲ 0.4%
24h▲ 1.9%
7d▲ 8.4%
14d▲ 5.8%
30d▼ 2.1%
1y▲ 78.3%
🏦Market Cap
$2.36B
Small Cap
📈Revenue Growth (YoY)
+48.8%
High Growth
📊Gross Margin
—
💵FCF Margin
5.6%
Moderate
⚖️P/S Ratio
1.1x
Cheap
Otter Score
61
Fair
📊
Analyst Ratings
Price
$4.48
Total
9
Raised
1
Lowered
2
Avg PT
$5.25
H / L
$6 / $5
| Institution | Action | Rating | Date |
|---|---|---|---|
Canaccord Genuity | Reiterated | Buy | 2026-07-21 |
UBS | Reiterated | Neutral | 2026-06-11 |
Leerink Partners | Reiterated | Market Perform | 2026-03-05 |
Citigroup | Reiterated | Neutral | 2023-08-11 |
Credit Suisse | Reiterated | Underperform | 2023-03-06 |
SVB Leerink | Reiterated | Market Perform | 2022-11-08 |
Cowen & Co. | Upgraded | Underperform → Market Perform | 2022-02-02 |
JP Morgan | Downgraded | Neutral → Underweight | 2021-07-12 |
B of A Securities | Downgraded | Neutral → Underperform | 2021-06-10 |
One row per institution, most recent rating